Thomas Brahier1, Jean-Yves Meuwly2, Olivier Pantet3, Marie-Josée Brochu Vez4, Hélène Gerhard Donnet4, Mary-Anne Hartley5,6, Olivier Hugli4, Noémie Boillat-Blanco1. 1. Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland. 2. Department of Radiology, University Hospital and University of Lausanne, Lausanne, Switzerland. 3. Intensive Care Unit, University Hospital and University of Lausanne, Lausanne, Switzerland. 4. Emergency Department, University Hospital and University of Lausanne, Lausanne, Switzerland. 5. Digital Global Health Department, Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland. 6. Machine Learning and Optimization Laboratory, École polytechnique fédérale de Lausanne, Lausanne, Switzerland.
Abstract
BACKGROUND: Lung ultrasonography (LUS) is a promising pragmatic risk-stratification tool in coronavirus disease 2019 (COVID-19). This study describes and compares LUS characteristics between patients with different clinical outcomes. METHODS: Prospective observational study of polymerase chain reaction-confirmed adults with COVID-19 with symptoms of lower respiratory tract infection in the emergency department (ED) of Lausanne University Hospital. A trained physician recorded LUS images using a standardized protocol. Two experts reviewed images blinded to patient outcome. We describe and compare early LUS findings (≤24 hours of ED presentation) between patient groups based on their 7-day outcome (1) outpatients, (2) hospitalized, and (3) intubated/dead. Normalized LUS score was used to discriminate between groups. RESULTS: Between 6 March and 3 April 2020, we included 80 patients (17 outpatients, 42 hospitalized, and 21 intubated/dead). Seventy-three patients (91%) had abnormal LUS (70% outpatients, 95% hospitalized, and 100% intubated/dead; P = .003). The proportion of involved zones was lower in outpatients compared with other groups (median [IQR], 30% [0-40%], 44% [31-70%], 70% [50-88%]; P < .001). Predominant abnormal patterns were bilateral and there was multifocal spread thickening of the pleura with pleural line irregularities (70%), confluent B lines (60%), and pathologic B lines (50%). Posterior inferior zones were more often affected. Median normalized LUS score had a good level of discrimination between outpatients and others with area under the ROC of .80 (95% CI, .68-.92). CONCLUSIONS: Systematic LUS has potential as a reliable, cheap, and easy-to-use triage tool for the early risk stratification in patients with COVID-19 presenting to EDs.
BACKGROUND: Lung ultrasonography (LUS) is a promising pragmatic risk-stratification tool in coronavirus disease 2019 (COVID-19). This study describes and compares LUS characteristics between patients with different clinical outcomes. METHODS: Prospective observational study of polymerase chain reaction-confirmed adults with COVID-19 with symptoms of lower respiratory tract infection in the emergency department (ED) of Lausanne University Hospital. A trained physician recorded LUS images using a standardized protocol. Two experts reviewed images blinded to patient outcome. We describe and compare early LUS findings (≤24 hours of ED presentation) between patient groups based on their 7-day outcome (1) outpatients, (2) hospitalized, and (3) intubated/dead. Normalized LUS score was used to discriminate between groups. RESULTS: Between 6 March and 3 April 2020, we included 80 patients (17 outpatients, 42 hospitalized, and 21 intubated/dead). Seventy-three patients (91%) had abnormal LUS (70% outpatients, 95% hospitalized, and 100% intubated/dead; P = .003). The proportion of involved zones was lower in outpatients compared with other groups (median [IQR], 30% [0-40%], 44% [31-70%], 70% [50-88%]; P < .001). Predominant abnormal patterns were bilateral and there was multifocal spread thickening of the pleura with pleural line irregularities (70%), confluent B lines (60%), and pathologic B lines (50%). Posterior inferior zones were more often affected. Median normalized LUS score had a good level of discrimination between outpatients and others with area under the ROC of .80 (95% CI, .68-.92). CONCLUSIONS: Systematic LUS has potential as a reliable, cheap, and easy-to-use triage tool for the early risk stratification in patients with COVID-19 presenting to EDs.
Authors: Yale Tung-Chen; Adriana Gil-Rodrigo; Ana Algora-Martín; Rafael Llamas-Fuentes; Pablo Rodríguez-Fuertes; Raquel Marín-Baselga; Blanca Alonso-Martínez; Elena Sanz Rodríguez; Pere Llorens Soriano; José-Manuel Ramos-Rincón Journal: Med Clin (Engl Ed) Date: 2022-07-05
Authors: Julio Cesar Garcia de Alencar; Julio Flavio Meirelles Marchini; Lucas Oliveira Marino; Sabrina Correa da Costa Ribeiro; Cauê Gasparotto Bueno; Victor Paro da Cunha; Felippe Lazar Neto; Rodrigo Antonio Brandão Neto; Heraldo Possolo Souza Journal: Ann Intensive Care Date: 2021-01-11 Impact factor: 6.925
Authors: Arthur W E Lieveld; Bram Kok; Kaoutar Azijli; Frederik H Schuit; Peter M van de Ven; Chris L de Korte; Robin Nijveldt; Frederik M A van den Heuvel; Bernd P Teunissen; Wouter Hoefsloot; Prabath W B Nanayakkara; Frank H Bosch Journal: J Am Coll Emerg Physicians Open Date: 2021-05-01
Authors: Thiago Thomaz Mafort; Rogério Rufino; Claudia Henrique da Costa; Mariana Soares da Cal; Laura Braga Monnerat; Patrícia Frascari Litrento; Laura Lizeth Zuluaga Parra; Arthur de Sá Earp de Souza Marinho; Agnaldo José Lopes Journal: Ultrasound J Date: 2021-04-09
Authors: Kosuke Yasukawa; Taro Minami; David R Boulware; Ayako Shimada; Ernest A Fischer Journal: J Intensive Care Med Date: 2021-03 Impact factor: 3.510